EX-99.1 2 uamy_ex991.htm PRESS RELEASE uamy_ex991.htm

EXHIBIT 99.1

 

   

United States Antimony Corporation

Reports First Quarter 2024 Results

 

THOMPSON FALLS, MT / ACCESSWIRE / May 15, 2024 / United States Antimony Corporation ("USAC" or the “Company” or “U.S. Antimony Corporation”), (NYSE American: UAMY) reports today its first quarter 2024 financial and operational results. Revenues for the first quarter of 2024 increased 28%, or $621k, to $2.83 million, compared to the first quarter of 2023, while cost of sales only increased 11%, or $192k, during the same period. This in-turn allowed gross profit to increase 108%, or $428k, quarter over quarter. Operating expenses increased $577k, or 183%, quarter over quarter to $892k, of which $205k of the increase was non-cash stock compensation.

 

Additionally, the company reported federal grant income in the first quarter of last year of $85k, however, no federal grant income was reported in the first quarter of 2024. The Company reported net income of $86k for the three months ended March 31, 2024.

 

As the Company announced on March 11, 2024, all operational activities in Mexico have ceased and this subsidiary is now reported as a “Discontinued Operation”. Overhead was substantially reduced, and business brokers are currently being interviewed to handle future disposition of these assets and/or entities. The historical drain of these operations on USAC have ceased with this decision.

 

The cash position of the Company at March 31, 2024 was $11.94 million, up $42k from December 31, 2023.

 

Commenting on the First Quarter 2024 operational and financial results, Mr. Gary C. Evans, Chairman and Co-CEO of U.S. Antimony Corporation stated, “We believe this first quarter of 2024 was truly a turning point for the Company. We discontinued the historical money losing operations in Mexico and continued to improve the operational performance of the U.S. based assets. The financial results reported today exemplify that occurrence. Most importantly, we have also protected our strong cash position and continue to maintain an extremely liquid balance sheet.”

 

While we are active in making necessary management and supervisor changes at Bear River Zeolite (three new hires since January 29, 2024) and continue to enhance operations with both mechanical and equipment changes having been made, we still experienced over 30 days of downtime during the first quarter of 2024. This is unacceptable. However, we are seeing a dramatic improvement in the overall operating environment at Bear River Zeolite which is leading to higher throughput, improved customer order delivery times, and safety. These necessary improvements will be further observed in future financial reports to our shareholders. The demand for this universally accepted hard mineral continues to expand with a wide diversity of customers. It is also noteworthy that the worldwide antimony metal market price has increased over 34% from $5.31 per pound on December 31, 2023 to $7.14 per pound as of May 10, 2024. Our Thompson Falls antimony processing facility continues to run seamlessly under the direction of Gus Gustavsen, the Divisional President.

 

As mentioned in our most recent conference call held on April 17, 2024, management is actively pursuing potential acquisition(s) in addition to new mineral leasing activities for both antimony and zeolite within the United States. Due to confidentiality and competitive reasons surrounding these ongoing activities, the Company is not yet in a position to further disclose these various transactions.

 

About USAC: 

 

United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover certain amounts of precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.  

 

 
1

 

 

United States Antimony Corporation and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

 

 

For the three months ended

 

 

 

March 31,

2024

 

 

March 31,

2023

 

REVENUES

 

$ 2,831,390

 

 

$ 2,210,844

 

COST OF REVENUES

 

 

2,008,486

 

 

 

1,816,001

 

GROSS PROFIT

 

 

822,904

 

 

 

394,843

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

General and administrative

 

 

455,394

 

 

 

141,271

 

Salaries and benefits

 

 

241,605

 

 

 

127,692

 

Professional fees

 

 

177,157

 

 

 

46,004

 

Loss on disposal of property, plant and equipment

 

 

17,494

 

 

 

-

 

TOTAL OPERATING EXPENSES

 

 

891,650

 

 

 

314,967

 

INCOME (LOSS) FROM OPERATIONS

 

 

(68,746 )

 

 

79,876

 

OTHER INCOME (EXPENSE):

 

 

 

 

 

 

 

 

Interest and investment income

 

 

150,851

 

 

 

122,372

 

Trademark and licensing income

 

 

6,368

 

 

 

7,525

 

Other miscellaneous income (expense)

 

 

(2,372 )

 

 

83,608

 

TOTAL OTHER INCOME

 

 

154,847

 

 

 

213,505

 

INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

 

86,101

 

 

 

293,381

 

Income tax expense

 

 

-

 

 

 

-

 

INCOME FROM CONTINUING OPERATIONS

 

 

86,101

 

 

 

293,381

 

Discontinued operations:

 

 

 

 

 

 

 

 

Loss from discontinued operations before income taxes

 

 

(408,869 )

 

 

(1,100,365 )

Income tax expense

 

 

-

 

 

 

-

 

Loss from discontinued operations

 

 

(408,869 )

 

 

(1,100,365 )

Net loss

 

 

(322,768 )

 

 

(806,984 )

Preferred dividends

 

 

(1,875 )

 

 

(1,875 )

Net loss available to common stockholders

 

($324,643)

 

 

($808,859)

 

Basic and diluted earnings per common share:

 

 

 

 

 

 

 

 

Income from continuing operations

 

$nil

 

 

$nil

 

Loss from discontinued operations

 

$nil

 

 

($0.01)

 

Net loss

 

$nil

 

 

($0.01)

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

 

107,908,306

 

 

 

107,260,472

 

Diluted

 

 

107,908,306

 

 

 

107,260,472

 

 

 
2

 

   

United States Antimony Corporation and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

March 31,

2024

 

 

December 31,

2023

 

ASSETS

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$ 11,941,298

 

 

$ 11,899,574

 

Certificates of deposit

 

 

22,216

 

 

 

72,898

 

Accounts receivable, net

 

 

1,057,742

 

 

 

625,256

 

Inventories, net

 

 

653,010

 

 

 

1,019,154

 

Prepaid expenses and other current assets

 

 

117,167

 

 

 

92,369

 

Current assets held for sale

 

 

215,110

 

 

 

366,955

 

Total current assets

 

 

14,006,543

 

 

 

14,076,206

 

Properties, plants and equipment, net

 

 

7,709,812

 

 

 

7,765,045

 

Restricted cash for reclamation bonds

 

 

55,060

 

 

 

55,061

 

Other assets

 

 

18,098

 

 

 

18,098

 

Non-current assets held for sale

 

 

6,215,574

 

 

 

6,180,585

 

Total assets

 

$ 28,005,087

 

 

$ 28,094,995

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

$ 403,441

 

 

$ 330,147

 

Accrued liabilities

 

 

117,822

 

 

 

109,341

 

Accrued liabilities - directors

 

 

167,059

 

 

 

124,810

 

Royalties payable

 

 

52,527

 

 

 

153,429

 

Long-term debt, current portion

 

 

7,170

 

 

 

28,443

 

Current liabilities held for sale

 

 

158,103

 

 

 

151,288

 

Total current liabilities

 

 

906,122

 

 

 

897,458

 

 

 

 

 

 

 

 

 

 

Stock payable to directors

 

 

38,542

 

 

 

38,542

 

Asset retirement obligations

 

 

1,119,832

 

 

 

1,101,561

 

Non-current liabilities held for sale

 

 

536,466

 

 

 

536,466

 

Total liabilities

 

 

2,600,962

 

 

 

2,574,027

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Preferred stock $0.01 par value, 10,000,000 shares authorized:

 

 

 

 

 

 

 

 

Series A:  0 shares issued and outstanding

 

 

-

 

 

 

-

 

Series B: 750,000 shares issued and outstanding (liquidation preference $969,375 and $967,500, respectively)

 

 

7,500

 

 

 

7,500

 

Series C: 177,904 shares issued and outstanding (liquidation preference $97,847 both years)

 

 

1,779

 

 

 

1,779

 

Series D:  0 shares issued and outstanding

 

 

-

 

 

 

-

 

Common stock, $0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares issued and outstanding, respectively

 

 

1,084,389

 

 

 

1,076,472

 

Additional paid-in capital

 

 

64,051,844

 

 

 

63,853,836

 

 

 

 

 

 

 

 

 

 

Accumulated deficit

 

 

(39,741,387 )

 

 

(39,418,619 )

Total stockholders' equity

 

 

25,404,125

 

 

 

25,520,968

 

Total liabilities and stockholders' equity

 

$ 28,005,087

 

 

$ 28,094,995

 

 

 
3

 

   

United States Antimony Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

March 31,

2024

 

 

March 31,

2023

 

CASH FLOWS FROM OPERATING ACTIVITIES OF CONTINUING OPERATIONS:

 

 

 

 

 

 

Net income from continuing operations

 

$ 86,101

 

 

$ 293,381

 

Adjustments to reconcile net income from continuing operations to net cash

 

 

 

 

 

 

 

 

provided (used) by operating activities of continuing operations:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

106,147

 

 

 

69,332

 

Accretion of asset retirement obligation

 

 

18,271

 

 

 

375

 

Loss on disposal of property, plant, and equipment

 

 

17,494

 

 

 

-

 

Write down of inventory to net realizable value

 

 

80,143

 

 

 

-

 

Share-based compensation

 

 

205,925

 

 

 

-

 

Other non-cash items

 

 

(15,695 )

 

 

2,041

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(432,486 )

 

 

(919,819 )

Inventories, net

 

 

286,001

 

 

 

(76,504 )

Prepaid expenses and other current assets

 

 

(24,798 )

 

 

(141,852 )

Accounts payable

 

 

73,294

 

 

 

158,942

 

Accrued liabilities

 

 

8,481

 

 

 

(55,425 )

Accrued liabilities – directors

 

 

42,249

 

 

 

19,746

 

Royalties payable

 

 

(100,902 )

 

 

(419,191 )

Net cash provided (used) by operating activities of continuing operations

 

 

350,225

 

 

 

(1,068,974 )

CASH FLOWS FROM INVESTING ACTIVITIES OF CONTINUING OPERATIONS:

 

 

 

 

 

 

 

 

Proceeds from redemption of certificates of deposit

 

 

50,682

 

 

 

-

 

Purchases of properties, plant, and equipment

 

 

(52,713 )

 

 

(501,202 )

Net cash used by investing activities of continuing operations

 

 

(2,031 )

 

 

(501,202 )

CASH FLOWS FROM FINANCING ACTIVITIES OF CONTINUING OPERATIONS:

 

 

 

 

 

 

 

 

Payments on dividends payable

 

 

-

 

 

 

(787,730 )

Principal payments on long-term debt

 

 

(21,273 )

 

 

(23,022 )

Net cash used by financing activities of continuing operations

 

 

(21,273 )

 

 

(810,752 )

Net cash flows provided (used) by continuing operations

 

 

326,921

 

 

 

(2,380,928 )

CASH FLOWS FROM DISCONTINUED OPERATIONS:

 

 

 

 

 

 

 

 

Net cash used by operating activities

 

 

(285,198 )

 

 

(1,204,818 )

Net cash used by investing activities

 

 

-

 

 

 

(113,568 )

Net cash flows used by discontinued operations

 

 

(285,198 )

 

 

(1,318,386 )

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

 

 

41,723

 

 

 

(3,699,314 )

|CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD

 

 

11,954,635

 

 

 

19,117,666

 

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD

 

$ 11,996,358

 

 

$ 15,418,352

 

 

 

 

 

 

 

 

 

 

NON-CASH FINANCING AND INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Common stock buyback and retirement

 

 

-

 

 

$ 202,980

 

Conversion of Preferred Series D to Common Stock

 

 

-

 

 

$ 16,926

 

 

 
4

 

 

Forward-Looking Statements: 

 

Readers should note that, in addition to the historical information contained herein, this press release may contain forward-looking statements within the meaning of, and intended to be covered by, the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based upon current expectations and beliefs concerning future developments and their potential effects on the Company including matters related to the Company's operations, pending contracts and future revenues, financial performance, and profitability, ability to execute on its increased production and installation schedules for planned capital expenditures, and the size of forecasted deposits. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties. In addition, other factors that could cause actual results to differ materially are discussed in the Company's most recent filings, including Form 10-K, Form 10-Q, and Form 8-K with the Securities and Exchange Commission.  

 

Forward-looking statements are typically identified by words such as “believe,” “expect,” “anticipate,” “intend,” “outlook,” “estimate,” “forecast,” “project,” “pro forma” and other similar words and expressions. Forward-looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made. Because forward-looking statements are subject to assumptions and uncertainties, actual results or future events could differ, possibly materially, from those anticipated in the forward-looking statements and future results could differ materially from historical performance. 

 

Contact:

United States Antimony Corporation

PO Box 643

47 Cox Gulch Rd.

Thompson Falls, Montana 59873-0643

406-606-4117

E-Mail: info@usantimony.com

 

Source: United States Antimony Corporation

 

 
5